drugset / Trial / NCT03143725

Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution

NCT03143725 ↗

Phase 1 Completed 12 enrolled Lakefront Biotherapeutics NV
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a Phase I, randomized, open-label, cross-over study with 4 single-dose treatments of GLPG1972 to compare the bioavailability of the oral wet granulation (WG) tablet relative to an oral solution and to the oral direct compression (DC) tablet after single dose intake in healthy male subjects and to evaluate the effect of food on the bioavailability of the WG oral tablet.

Timeline

Start
2017-04-14
Primary completion
2017-06-06
Completion
2017-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ALDUMASTAT Small molecule — Oral

Indications

No indication recorded.